Dentsply Sirona Inc

XRAY: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
!$LOCK|wLLOCK|yZSwGL

Dentsply Sirona Earnings: Weak Recovery Momentum Unchanged as Soft Volume Weighs on Results

Dentsply Sirona delivered revenue and adjusted EPS declines of 4% and 1%, respectively, during the second quarter. Both figures came ahead of FactSet consensus. Full-year guidance for revenue ($3.5-3.6 billion) and EPS ($1.40-1.50) is unchanged. Shares are down 3% after hours.

Sponsor Center